Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 453

1.

In Regard to Vaidya et al.

Haviland JS, Bliss JM, Bentzen SM, Cuzick J.

Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):954-5. doi: 10.1016/j.ijrobp.2015.05.026. Epub 2015 Jul 14. No abstract available.

PMID:
26194664
2.

Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort.

Cuzick J, Stone S, Fisher G, Yang ZH, North BV, Berney DM, Beltran L, Greenberg D, Møller H, Reid JE, Gutin A, Lanchbury JS, Brawer M, Scardino P.

Br J Cancer. 2015 Jul 28;113(3):382-9. doi: 10.1038/bjc.2015.223. Epub 2015 Jun 23.

PMID:
26103570
3.

Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer.

Dowsett M, Sestak I, Buus R, Lopez-Knowles E, Mallon E, Howell A, Forbes JF, Buzdar A, Cuzick J.

Clin Cancer Res. 2015 Jun 15;21(12):2763-70. doi: 10.1158/1078-0432.CCR-14-2842.

PMID:
26078431
4.

Background risk of breast cancer influences the association between alcohol consumption and mammographic density.

Trinh T, Christensen SE, Brand JS, Cuzick J, Czene K, Sjölander A, Bälter K, Hall P.

Br J Cancer. 2015 Jun 30;113(1):159-65. doi: 10.1038/bjc.2015.185. Epub 2015 Jun 2.

PMID:
26035701
5.

Gardasil 9 joins the fight against cervix cancer.

Cuzick J.

Expert Rev Vaccines. 2015 Aug;14(8):1047-9. doi: 10.1586/14760584.2015.1051470. Epub 2015 May 31.

PMID:
26028344
6.

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.

Gnant M, Sestak I, Filipits M, Dowsett M, Balic M, Lopez-Knowles E, Greil R, Dubsky P, Stoeger H, Rudas M, Jakesz R, Ferree S, Cowens JW, Nielsen T, Schaper C, Fesl C, Cuzick J.

Ann Oncol. 2015 Aug;26(8):1685-91. doi: 10.1093/annonc/mdv215. Epub 2015 May 1.

PMID:
25935792
7.

Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial.

Mote PA, Gompel A, Howe C, Hilton HN, Sestak I, Cuzick J, Dowsett M, Hugol D, Forgez P, Byth K, Graham JD, Clarke CL.

Breast Cancer Res Treat. 2015 Jun;151(2):309-18. doi: 10.1007/s10549-015-3397-0. Epub 2015 Apr 28.

PMID:
25917868
8.

Background risk of breast cancer and the association between physical activity and mammographic density.

Trinh T, Eriksson M, Darabi H, Bonn SE, Brand JS, Cuzick J, Czene K, Sjölander A, Bälter K, Hall P.

Breast Cancer Res. 2015 Apr 2;17(1):50.

9.

Markers for the identification of late breast cancer recurrence.

Sestak I, Cuzick J.

Breast Cancer Res. 2015 Jan 27;17:10. doi: 10.1186/s13058-015-0516-0.

10.

Atypical hyperplasia of the breast.

Brentnall AR, Cuzick J.

N Engl J Med. 2015 Mar 26;372(13):1269-70. doi: 10.1056/NEJMc1501046#SA1. No abstract available.

PMID:
25806930
11.

Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?

Phillips KA, Steel EJ, Collins I, Emery J, Pirotta M, Mann GB, Butow P, Hopper JL, Trainer A, Moreton J, Antoniou AC, Cuzick J, Keogh L.

Aust J Prim Health. 2015 Feb 24. doi: 10.1071/PY14156. [Epub ahead of print]

PMID:
25705982
12.

A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.

Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED Jr, Ngan Y, Petersen LK, Lazcano-Ponce E, Pitisuttithum P, Restrepo JA, Stuart G, Woelber L, Yang YC, Cuzick J, Garland SM, Huh W, Kjaer SK, Bautista OM, Chan IS, Chen J, Gesser R, Moeller E, Ritter M, Vuocolo S, Luxembourg A; Broad Spectrum HPV Vaccine Study.

N Engl J Med. 2015 Feb 19;372(8):711-23. doi: 10.1056/NEJMoa1405044.

PMID:
25693011
13.

PSA testing for prostate cancer screening--authors' reply.

Cuzick J, Thorat MA.

Lancet Oncol. 2015 Jan;16(1):e3. doi: 10.1016/S1470-2045(14)71189-1. Epub 2014 Dec 29. No abstract available.

PMID:
25638552
14.

Visual inspection after acetic acid (VIA) is highly heterogeneous in primary cervical screening in Amazonian Peru.

Almonte M, Ferreccio C, Luciani S, Gonzales M, Delgado JM, Santos C, Alvarez M, Cuzick J, Sasieni P.

PLoS One. 2015 Jan 30;10(1):e0115355. doi: 10.1371/journal.pone.0115355. eCollection 2015.

15.

The Interpretive Variability of Cervical Biopsies and Its Relationship to HPV Status.

Stoler MH, Ronnett BM, Joste NE, Hunt WC, Cuzick J, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Am J Surg Pathol. 2015 Jun;39(6):729-36. doi: 10.1097/PAS.0000000000000381.

16.

Detection of human papillomavirus 16, 18, and 45 in women with ASC-US cytology and the risk of cervical precancer: results from the CLEAR HPV study.

Castle PE, Cuzick J, Stoler MH, Wright TC Jr, Reid JL, Dockter J, Giachetti C, Getman D.

Am J Clin Pathol. 2015 Feb;143(2):160-7. doi: 10.1309/AJCPLCD8TTOMLJTB.

PMID:
25596241
17.

Update on breast cancer risk prediction and prevention.

Sestak I, Cuzick J.

Curr Opin Obstet Gynecol. 2015 Feb;27(1):92-7. doi: 10.1097/GCO.0000000000000153.

PMID:
25517358
18.

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.

Cuzick J, Sestak I, Cawthorn S, Hamed H, Holli K, Howell A, Forbes JF; IBIS-I Investigators.

Lancet Oncol. 2015 Jan;16(1):67-75. doi: 10.1016/S1470-2045(14)71171-4. Epub 2014 Dec 11.

19.

Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial.

Sestak I, Singh S, Cuzick J, Blake GM, Patel R, Gossiel F, Coleman R, Dowsett M, Forbes JF, Howell A, Eastell R.

Lancet Oncol. 2014 Dec;15(13):1460-8. doi: 10.1016/S1470-2045(14)71035-6. Epub 2014 Nov 11. Erratum in: Lancet Oncol. 2014 Dec;15(13):e587.

20.

Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management.

Cuzick J, Myers O, Hunt WC, Saslow D, Castle PE, Kinney W, Waxman A, Robertson M, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Int J Cancer. 2015 Jun 15;136(12):2854-63. doi: 10.1002/ijc.29337. Epub 2014 Dec 1.

PMID:
25447979
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk